scorecardresearch
Add as a preferred source on Google
Wednesday, April 22, 2026
TopicHIV

Topic: HIV

‘Rooted in data’: How Centre defended blood donation ban on gay men, sex workers, trans people before SC

Govt's reasoning rests on the principle that the health of the blood recipient must take precedence over the desire of any individual to donate.

China’s method to boost birth rates in country – adding tax to condoms

Under the revised value-added tax law, consumers will pay a 13% levy on items that had been exempted since 1993, when China enforced a strict one-child policy.

Safe access to HIV medication is wrapped in stigma. This non-profit is changing that

Getting quick access to PEP is important because the course must be started within 72 hours of a potential exposure to HIV to be effective. That's the gap the directory aims to fill.

Eliminating AIDS has been an uphill battle. But Melbourne researchers just got one step closer

Bengaluru: Eliminating AIDS is a Sisyphian challenge. Treatments mostly miss the Human Immunodeficiency Virus (HIV) that are hidden in the body. But in a...

What is Hyderabad’s role in global acetone trade? New book explores the city beyond biryani

In 'Beyond Biryani', journalist Dinesh C Sharma unpacks the city's identity beyond its clichés and stereotypes, highlighting its contributions to industrial & scientific breakthroughs.

Why Indian patients groups are opposing patent requests for blockbuster HIV drug lenacapavir

Granting patents to US firm Gilead Sciences for lenacapavir could hinder global efforts to end AIDS & restrict access to affordable generics in India, warn civil society organisations.

Meth addiction, HIV, and a struggling health system plague Fiji as tourism grows

With children as young as nine being treated for addiction, and with crime statistics and HIV and AIDS cases climbing dramatically, police have called for a state of emergency.

Llama nanobodies can target HIV-1 strains & Sun starts next solar cycle halfway throught current one

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

Hope like never before — a drug that promises 100% protection from HIV

Lenacapavir, developed by Gilead Sciences, was tested as a pre-exposure prophylaxis in African women & is now being tested in other groups who are among the most vulnerable to HIV.

Global life expectancy on the rise — men and women to live more than 4 years longer by 2050

ScientiFix, our weekly feature, offers you a summary of the top global science stories of the week, with links to their sources.

On Camera

China is worried about US–Philippines military exercises. It’s too close for comfort

Official Chinese statements have described the drills as destabilising, warning that they risk escalation and that the participating countries are 'playing with fire.'

FTA partners drive India’s trade surge as reliance on non-FTA countries dips, says NITI Aayog report

Share of trade with FTA partners rose from 4.6% in 2006 to 28.8% in 2024. India is currently negotiating or advancing agreements with US, Israel, GCC, Canada & Mexico.

Japan overhauls post-World War II pacifist military approach, lifts restrictions on defence exports

Since October last year, Japan PM Sanae Takaichi has planned to increase defence spending target to 2 percent of GDP.

Trump, Netanyahu’s Iran gamble: The regime change rebound

American objectives are unmet. They neither have muscle nor motivation to resume the war. As for Iran, the regime didn’t just survive, it’s now led by more radical individuals.